Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Zhejiang University
Northwestern University
Case Comprehensive Cancer Center
University of Pennsylvania
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
University of Kansas Medical Center
Indiana University